Brinker Capital Investments, LLC Exagen Inc. Transaction History

Brinker Capital Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	BUY	$2.69 - $8.68 $22,916 - $73,944	8,519 Added 9.4%	99,115 $269,000
Q2 2022 Jul 18, 2022	SELL	$4.18 - $7.74 $10,959 - $20,294	-2,622 Reduced 2.81%	90,596 $520,000
Q1 2022 May 16, 2022	BUY	$7.12 - $11.06 $155,394 - $241,384	21,825 Added 30.57%	93,218 $749,000
Q4 2021 Feb 08, 2022	SELL	$8.97 - $14.08 $438,148 - $687,751	-48,846 Reduced 40.62%	71,393 $830,000
Q2 2021 Aug 03, 2021	BUY	$12.4 - $17.92 $1.49 Million - $2.15 Million	120,239 New	120,239 $1.8 Million

6.29M

2.5K

200

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $51.1M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Brinker Capital Investments, LLC with notifications on news.